Search results
Showing 6196 to 6210 of 7691 results
Infection control: prevention of healthcare-associated infection in primary and community care (CG2)
This guidance has been updated and replaced by NICE guideline CG139.
This guideline has been updated and replaced by NICE guideline CG137.
Falls: the assessment and prevention of falls in older people (CG21)
This guideline has been updated and replaced by NICE guideline CG161.
This guideline has been updated and replaced by NICE guideline CG113.
Depression: management of depression in primary and secondary care (CG23)
This guidance has been updated and replaced by NICE guideline CG90.
This guideline has been updated and replaced by NICE guideline CG121.
Violence: short-term management for over 16s in psychiatic and emergency departments (CG25)
This guideline has been updated and replaced by NICE guideline NG10.
This guidance has been updated and replaced by NICE guideline NG116.
This guidance has been updated and replaced by NICE's diagnostics guidance 56.
This evidence summary has been withdrawn because licensed products are now available and the off-label indication has been replaced by NICE guideline NG71.
Multidrug resistant urinary tract infections: fosfomycin trometamol (ESUOM17)
This evidence summary has been withdrawn because a product containing fosfomycin trometamol with a marketing authorisation for treating multidrug resistant urinary tract infections is now available in the UK.
Type 1 diabetes mellitus in adults: high-strength insulin glargine 300 units/ml (Toujeo) (ESNM62)
This evidence summary has been updated and replaced by NICE guideline NG17.
Chronic obstructive pulmonary disease: beclometasone/formoterol (Fostair) (ESNM47)
This evidence summary has been updated and replaced by NICE guideline 115.
This evidence summary has been updated and replaced by NICE guideline 115.
This evidence summary has been updated and replaced by NICE advice ESNM24.